165 related articles for article (PubMed ID: 11875724)
1. Influence of pathological tumour variables on long-term survival in resectable gastric cancer.
Cuschieri A; Talbot IC; Weeden S;
Br J Cancer; 2002 Mar; 86(5):674-9. PubMed ID: 11875724
[TBL] [Abstract][Full Text] [Related]
2. Pathological prognostic factors in the second British Stomach Cancer Group trial of adjuvant therapy in resectable gastric cancer.
Yu CC; Levison DA; Dunn JA; Ward LC; Demonakou M; Allum WH; Hallisey MT
Br J Cancer; 1995 May; 71(5):1106-10. PubMed ID: 7734309
[TBL] [Abstract][Full Text] [Related]
3. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Factors for Survival in Node-Negative Gastric Cancer Patients Who Underwent Curative Resection.
Zhou Y; Cui JG; Huang F; Zhang A; Li C; Zhao ZC; Li WD; Fu WH
Scand J Surg; 2017 Sep; 106(3):235-240. PubMed ID: 28376652
[TBL] [Abstract][Full Text] [Related]
5. Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer.
Bilici A; Seker M; Ustaalioglu BB; Yilmaz B; Doventas A; Salepci T; Gumus M
Med Oncol; 2010 Sep; 27(3):975-84. PubMed ID: 19885750
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemically detected free peritoneal tumour cells (FPTC) are a strong prognostic factor in gastric carcinoma.
Nekarda H; Gess C; Stark M; Mueller JD; Fink U; Schenck U; Siewert JR
Br J Cancer; 1999 Feb; 79(3-4):611-9. PubMed ID: 10027338
[TBL] [Abstract][Full Text] [Related]
7. Adverse prognostic impact of splenectomy on survival in gastric carcinoma patients: Regression and propensity score matching analysis of 1074 patients.
Jeong O; Kim HG; Ryu SY; Park YK; Jung MR
PLoS One; 2018; 13(9):e0203820. PubMed ID: 30204783
[TBL] [Abstract][Full Text] [Related]
8. Is the new UICC staging system of gastric cancer reasonable? (Comparison of 5-year survival rate of gastric cancer by old and new UICC stage classification).
Kim JP; Yang HK; Oh ST
Surg Oncol; 1992 Jun; 1(3):209-13. PubMed ID: 1341253
[TBL] [Abstract][Full Text] [Related]
9. Large metastatic lymph node size, especially more than 2 cm: independent predictor of poor prognosis in node-positive gastric carcinoma.
Cheong O; Oh ST; Kim BS; Yook JH; Kim JH; Im JT; Park GC
World J Surg; 2008 Feb; 32(2):262-6. PubMed ID: 18064519
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of intratumoral natural killer cells in gastric carcinoma.
Ishigami S; Natsugoe S; Tokuda K; Nakajo A; Che X; Iwashige H; Aridome K; Hokita S; Aikou T
Cancer; 2000 Feb; 88(3):577-83. PubMed ID: 10649250
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357
[TBL] [Abstract][Full Text] [Related]
12. [Value of tumor deposits in staging and prognostic evaluation in gastric cancer patients].
Liang W; Zhou Z; Cui J; Xi H; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):277-282. PubMed ID: 28338160
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic factors for gastric cancer without lymph node involvement].
Tapia O; Villaseca M; Bellolio E; Araya JC; Roa JC
Rev Med Chil; 2011 Apr; 139(4):432-8. PubMed ID: 21879180
[TBL] [Abstract][Full Text] [Related]
14. [Pathological staging criteria for carcinoma in the remnant stomach: an exploratory study].
Gao Z; Zhao X; Jiang K; Wang B; Li Y; Ye Y; Wang S
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):514-521. PubMed ID: 29774932
[TBL] [Abstract][Full Text] [Related]
15. Gastric cancers in Singapore: poor prognosis arising from late presentation.
Koong HN; Chan HS; Nambiar R; Soo KC; Ho J; Ng HS; Ng EH
Aust N Z J Surg; 1996 Dec; 66(12):813-5. PubMed ID: 8996060
[TBL] [Abstract][Full Text] [Related]
16. Routinely staging gastric cancer with
Findlay JM; Antonowicz S; Segaran A; El Kafsi J; Zhang A; Bradley KM; Gillies RS; Maynard ND; Middleton MR
Eur Radiol; 2019 May; 29(5):2490-2498. PubMed ID: 30643947
[TBL] [Abstract][Full Text] [Related]
17. Recurrence in node-negative advanced gastric cancer: Novel findings from an in-depth pathological analysis of prognostic factors from a multicentric series.
Baiocchi GL; Molfino S; Baronchelli C; Giacopuzzi S; Marrelli D; Morgagni P; Bencivenga M; Saragoni L; Vindigni C; Portolani N; Botticini M; De Manzoni G
World J Gastroenterol; 2017 Dec; 23(45):8000-8007. PubMed ID: 29259375
[TBL] [Abstract][Full Text] [Related]
18. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
19. Norwegian multicentre study of survival and prognostic factors in patients undergoing curative resection for gastric carcinoma. The Norwegian Stomach Cancer Trial.
Haugstvedt TK; Viste A; Eide GE; Söreide O
Br J Surg; 1993 Apr; 80(4):475-8. PubMed ID: 8495315
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Perineural Invasion in Resected Gastric Cancer Patients According to Lauren Histotype.
De Franco L; Marrelli D; Voglino C; Vindigni C; Ferrara F; Di Mare G; Iudici L; Marini M; Roviello F
Pathol Oncol Res; 2018 Apr; 24(2):393-400. PubMed ID: 28555306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
